Search
familial hypocalciuric hypercalcemia
Epidemiology:
- rare
Pathology:
- reduced activity of Ca+2 sensing receptor (CASR)
- FHH is characterized by altered Ca+2 homeostasis
Genetics:
- associated with a defect in Ca+2 sensing receptor (CASR) in parathyroid cells
Clinical manifestations:
- generally asymptomatic
Laboratory:
1) serum calcium: mild to moderate hypercalcemia
2) urine calcium:
- low urinary Ca+2 excretion in distinction to hyperparathyroidism
- 24 hour urine calcium < 200 mg/24 hours
- urine calcium/creatinine ratio < 0.01 [1]
3) serum creatinine & urine creatinine for calculation of calcium to creatinine clearance ratio [1]
- calcium [urine] (mg/dL) x creatinine [serum] (mg/dL)
---------------------------------------------------- calcium [serum] (mg/dL) x creatinine [urine] (mg/dL)
- a ratio of < 0.01 suggests familial hypocalciuric hypercalcemia
4) serum PTH is variable, may be high or inappropriately normal
5) CASR gene mutation if diagnosis is clinically ambiguous [1]
Differential diagnosis:
- hyperparathyroidism
- idiopathic hypercalciuria
- absorptive hypercalciuria
Management:
- benign condition
- does not resolve with parathyroidectomy
- no treatment indicated [1,4]
Specific
familial hypocalciuric hypercalcemia type I
familial hypocalciuric hypercalcemia type II
familial hypocalciuric hypercalcemia type III
General
genetic disease of the endocrine system
hypercalcemia
References
- Medical Knowledge Self Assessment Program (MKSAP) 11, 16, 17, 18.
American College of Physicians, Philadelphia 1998, 2015, 2018.
- Medical Knowledge Self Assessment Program (MKSAP) 20
American College of Physicians, Philadelphia 2025
- Christensen SE, Nissen PH, Vestergaard P, Mosekilde L.
Familial hypocalciuric hypercalcaemia: a review.
Curr Opin Endocrinol Diabetes Obes. 2011 Dec;18(6):359-70
PMID: 21986511
- Shinall MC Jr, Dahir KM, Broome JT.
Differentiating familial hypocalciuric hypercalcemia from
primary hyperparathyroidism.
Endocr Pract. 2013 Jul-Aug;19(4):697-702. Review.
PMID: 23425644
- Hoppner J, Sinningen K, Raimann A, et al.
Disorders of the calcium sensing signaling pathway: from familial hypocalciuric
hypercalcemia (FHH) to life threatening conditions in infancy.
J Clin Med. 2022;11:2595.
PMID: 35566721